- Q1 2024 AstraZeneca PLC Earnings Call TranscriptApr 25, 2024€141.15 (+6.45%)Earnings
- AstraZeneca PLC Sustainability 2023 Highlights Summary Call TranscriptMar 22, 2024
- Q4 2023 AstraZeneca PLC Earnings Call TranscriptFeb 08, 2024€115.95 (-6.04%)Earnings
- AstraZeneca PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 AstraZeneca PLC Earnings Call TranscriptNov 09, 2023€120.95 (+2.41%)Earnings
- Q2 2023 AstraZeneca PLC Earnings Call TranscriptJul 28, 2023€130 (+3.88%)Earnings
- AstraZeneca PLC at ASCO Investor Meeting (Virtual) TranscriptJun 05, 2023
- Q1 2023 AstraZeneca PLC Earnings Call TranscriptApr 27, 2023€133.4 (-0.30%)Earnings
- Q4 2022 AstraZeneca PLC Earnings Call TranscriptFeb 09, 2023€126.55 (+4.59%)Earnings
- Q4 2022 AstraZeneca PLC Earnings Presentation (Pre-Recorded) TranscriptFeb 09, 2023
- Q3 2022 AstraZeneca PLC Earnings Presentation TranscriptNov 10, 2022
- Q2 2022 AstraZeneca PLC Earnings Call TranscriptJul 29, 2022€130.5 (-0.34%)Earnings
- AstraZeneca PLC Meet AZN management: American Society of Clinical Oncology 2022 Annual Meeting TranscriptJun 06, 2022
- Q1 2022 AstraZeneca PLC Earnings Call TranscriptApr 29, 2022€127.9 (+2.20%)Earnings
- AstraZeneca PLC Investor Science Conference Call: ASCO GU 2022 TranscriptFeb 23, 2022
- Full Year 2021 AstraZeneca PLC Earnings Call TranscriptFeb 10, 2022€103.34 (+3.73%)Earnings
- AstraZeneca PLC Investor science conference call: ASCO GI 2022 TranscriptJan 24, 2022
- AstraZeneca PLC at OTC Markets and Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 17, 2021
- Q3 2021 AstraZeneca PLC Earnings Call TranscriptNov 12, 2021€103.02 (-6.58%)Earnings
- AstraZeneca PLC ESMO Investor Science Conference Call TranscriptSep 20, 2021
- Q2 2021 AstraZeneca PLC Earnings Call TranscriptJul 29, 2021€97.18 (+0.05%)Earnings
- AstraZeneca PLC Meet AZN Management: Oncology - 2021 ASCO Annual Meeting TranscriptJun 07, 2021
- Q1 2021 AstraZeneca PLC Earnings Call TranscriptApr 30, 2021Earnings
- AstraZeneca PLC BioPharmaceuticals Virtual Event - New CVRM: Emerging Pipeline TranscriptMar 25, 2021
- AstraZeneca PLC BioPharmaceuticals Virtual Event - Opening and Q&A Session TranscriptMar 25, 2021
- Full Year 2020 AstraZeneca PLC Earnings Call TranscriptFeb 11, 2021€82.6 (-0.18%)Earnings
- AstraZeneca PLC to Acquire Alexion Pharmaceuticals Inc Call TranscriptDec 12, 2020
- Q3 2020 AstraZeneca PLC Earnings Call TranscriptNov 05, 2020€94.55 (-0.10%)Earnings
- AstraZeneca PLC Investor Conference Call: Farxiga's DAPA-CKD Trial at ESC 2020 TranscriptAug 30, 2020
- Q2 2020 AstraZeneca PLC Earnings Call TranscriptJul 30, 2020€98.46 (+2.55%)Earnings
- AstraZeneca PLC at ASCO Virtual Scientific Program TranscriptJun 01, 2020
- Q1 2020 AstraZeneca PLC Earnings Call TranscriptApr 29, 2020€94.15 (-0.33%)Earnings
- Silence Therapeutics PLC Collaboration With AstraZeneca and R&D Update Call TranscriptMar 25, 2020
- Full Year 2019 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2020€87.79 (-3.51%)Earnings
- AstraZeneca PLC Investor Science Conference Call - ASH 2019 TranscriptDec 10, 2019
- AstraZeneca PLC Investor Science Conference Call - ACR 2019 TranscriptNov 13, 2019
- AstraZeneca PLC Investor Science Conference Call - ASN 2019 TranscriptNov 10, 2019
- Q3 2019 AstraZeneca PLC Earnings Call TranscriptOct 24, 2019€84.82 (+5.50%)Earnings
- AstraZeneca PLC Investor Science Conference Call: ESMO 2019 TranscriptSep 30, 2019
- AstraZeneca PLC Investor Science Conference Call: Farxiga's DAPA-HF trial at ESC TranscriptSep 01, 2019
- Q2 2019 AstraZeneca PLC Earnings Call TranscriptJul 25, 2019€77.49 (+7.48%)Earnings
- AstraZeneca PLC at ASCO Annual Meeting TranscriptJun 03, 2019
- AstraZeneca PLC Annual Shareholders Meeting TranscriptApr 26, 2019
- Q1 2019 AstraZeneca PLC Earnings Call TranscriptApr 26, 2019€67.84 (-1.82%)Earnings
- AstraZeneca PLC to Discuss Strategic Collaboration in Oncology of Trastuzumab Deruxtecan (DS-8201) with Daiichi Sankyo Co Ltd Call TranscriptMar 29, 2019
- Daiichi Sankyo Co Ltd and AstraZeneca PLC DS-8201 Strategic Collaboration Presentation TranscriptMar 29, 2019
- Full Year 2018 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2019€70.32 (+7.06%)Earnings
AstraZeneca PLC Investor Conference Call: Farxiga's DAPA-CKD Trial at ESC 2020 Transcript
Good afternoon, everybody. Thank you so much for joining us for this very exciting discussion today on a very, very important set of data that we have just presented at the ESC.
So if we move to the Slide 3, this shows you the agenda for today. I will give you a short introduction, and then you will hear Professor Hiddo Heerspink present the data, and then we'll move to a Q&A.
So if we move to Slide 4, just want to say that the presenters for today will be Hiddo, of course; David Wheeler from University College London; Ruud Dobber, our EVP for our BioPharmaceuticals Business Unit; Mene Pangalos, the EVP for BioPharma R&D; and Elisabeth Björk, who is with the SVP for CVRM. They are available for the Q&A, and we may also call on other team members who are with us today in case we have additional questions.
We move to Slide 5. This slide actually shows you the, I would think, the incredible journey that Farxiga has been on from the early days when basically everybody saw this molecule as a simple diabetes drug
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)